FRQ-31816-26804
3 vaccinations
5 coded responses
30 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 941 / CA
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-20
Dose 1 — Pfizer-BioNTech
-
2021-01-21
Registered in v-safe
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-02-03
- 2021-02-10
-
2021-02-13
Dose 2 — Pfizer-BioNTech
- 2021-02-13
-
2021-02-14
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: Enlarged axillary lymph node of the associated arm (left)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-15
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Fatigue or tirednessFree text: Enlarged left axillary lymph node (associated injection side)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-16
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Enlarged axillary lymph nodeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-17
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: improved axillary lymph node enlargementMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-03-20
- 2021-03-27
- 2021-05-15
- 2021-08-16
-
2021-10-13
Dose 3 — Pfizer-BioNTech
-
2021-11-06
Survey response — day 21, dose 3MedDRA: Chills, Fatigue, Hyperhidrosis, Lymphadenopathy, Myalgia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: At the 24-36 hours post 3rd vax I experienced enlarged axillary lymph nodes (left arm vaccine was given), chills, sweating, fatigue and muscle aches for that period. At the 36 hour point, most of the symptoms resolved with the axillary ln reducing.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-10
- 2021-11-17
- 2021-11-24
- 2022-01-12
- 2022-04-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-20 | Pfizer-BioNTech | |
| 2 | 2021-02-13 | Pfizer-BioNTech | |
| 3 | 2021-10-13 | Pfizer-BioNTech | No |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Enlarged axillary lymph node of the associated arm (left)
Systemic reaction (other): Enlarged left axillary lymph node (associated injection side)
Systemic reaction (other): Enlarged axillary lymph node
Systemic reaction (other): improved axillary lymph node enlargement
Release 10 — day 21, dose 3
Symptoms: At the 24-36 hours post 3rd vax I experienced enlarged axillary lymph nodes (left arm vaccine was given), chills, sweating, fatigue and muscle aches for that period. At the 36 hour point, most of the symptoms resolved with the axillary ln reducing. cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hyperhidrosis | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release